Nanhee Song
Jeonju, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Self-boosting targeted anticancer therapy via cancer cell self-reprogramming with GGT-targeting oxidative stress nanoamplifiers.
Journal: Theranostics
Published: July 04, 2025
Self-assembling heterodimeric prodrug nanoparticles for dual-targeted cancer therapy via the disruption of redox homeostasis and Pin1 degradation.
Journal: Biomaterials
Published: March 04, 2025
Comparison of Ultrasound Contrast between H2O2-Responsive Nanoparticles and Microbubble Contrast According to Muscle Injury in Rat Models.
Journal: Diagnostics (Basel, Switzerland)
Published: September 05, 2023
Tumor-targeted and stimulus-responsive polymeric prodrug nanoparticles to enhance the anticancer therapeutic efficacy of doxorubicin.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 13, 2023
Nanoassemblies of Self-Immolative Boronate-Bridged Retinoic Acid Dimeric Prodrug as a Clot-Targeted Self-Deliverable Antithrombotic Nanomedicine.
Journal: ACS nano
Published: June 29, 2023
Tumor-targeting oxidative stress nanoamplifiers as anticancer nanomedicine with immunostimulating activity.
Journal: Biomaterials science
Published: October 12, 2022
Oxidative Stress Amplifying Polyprodrug Micelles as Drug Carriers for Combination Anticancer Therapy.
Journal: Biomacromolecules
Published: August 25, 2022
Self-deliverable and self-immolative prodrug nanoassemblies as tumor targeted nanomedicine with triple cooperative anticancer actions.
Journal: Biomaterials
Published: February 09, 2022
Last Updated: 09/26/2026